Global Peptide Screening Service Production, Demand and Key Producers, 2022-2028

October 2022 | 115 pages | ID: GEBB6F5031BEEN
GlobalInfoResearch

Abstracts

This report studies the global Peptide Screening Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Peptide Screening Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peptide Screening Service that contribute to its increasing demand across many markets.

The global Peptide Screening Service market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Peptide Screening Service total market, 2017-2028, (USD Million)

Global Peptide Screening Service total market by region & country, CAGR, 2017-2028, (USD Million)

U.S. VS China: Peptide Screening Service total market, key domestic companies and share, (USD Million)

Global Peptide Screening Service revenue by player and market share 2017-2022, (USD Million)

Global Peptide Screening Service total market by Type, CAGR, 2017-2028, (USD Million)

Global Peptide Screening Service total market by Application, CAGR, 2017-2028, (USD Million)

This reports profiles major players in the global Peptide Screening Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pepscan, Orbit Discovery, Creative Biolabs, GenScript, Creative Peptides, Eurogentec, Bio-Synthesis, JPT Peptide Technologies and Antibody Design Labs, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Peptide Screening Service market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Peptide Screening Service Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Peptide Screening Service Market, Segmentation by Type

• Solid-Phase Screening
• Solution-Sorting Screening
• Cell-based Screening
• In Vivo Screening
• Ex Vivo Screening

Global Peptide Screening Service Market, Segmentation by Application

• Structural Biology
• Peptide Drug Development
• Vaccine Development

Companies Profiled:

• Pepscan
• Orbit Discovery
• Creative Biolabs
• GenScript
• Creative Peptides
• Eurogentec
• Bio-Synthesis
• JPT Peptide Technologies
• Antibody Design Labs
• HLA Proteins
• Synbio Technologies
• Lugen SCI
• Quimigen
• IRBM
• BIOSTEM

Key Questions Answered

1. How big is the global Peptide Screening Service market?

2. What is the demand of the global Peptide Screening Service market?

3. What is the year over year growth of the global Peptide Screening Service market?

4. What is the total value of the global Peptide Screening Service market?

5. Who are the major players in the global Peptide Screening Service market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Peptide Screening Service Introduction
1.2 World Peptide Screening Service Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Peptide Screening Service Total Market by Region
  1.3.1 World Peptide Screening Service Market Size by Region (2017-2028)
  1.3.2 United States Peptide Screening Service Market Size (2017-2028)
  1.3.3 China Peptide Screening Service Market Size (2017-2028)
  1.3.4 Europe Peptide Screening Service Market Size (2017-2028)
  1.3.5 Japan Peptide Screening Service Market Size (2017-2028)
  1.3.6 South Korea Peptide Screening Service Market Size (2017-2028)
  1.3.7 ASEAN Peptide Screening Service Market Size (2017-2028)
  1.3.8 India Peptide Screening Service Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Peptide Screening Service Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Peptide Screening Service Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 WORLD PEPTIDE SCREENING SERVICE COMPANIES COMPETITIVE ANALYSIS

2.1 World Peptide Screening Service Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
  2.2.1 Global Peptide Screening Service Industry Rank of Major Players
  2.2.2 Global Concentration Ratios (CR4) for Peptide Screening Service in 2021
  2.2.3 Global Concentration Ratios (CR8) for Peptide Screening Service in 2021
2.3 Peptide Screening Service Company Evaluation Quadrant
2.4 Peptide Screening Service Market: Overall Company Footprint Analysis
  2.4.1 Peptide Screening Service Market: Region Footprint
  2.4.2 Peptide Screening Service Market: Company Product Type Footprint
  2.4.3 Peptide Screening Service Market: Company Product Application Footprint
2.5 Competitive Environment
  2.5.1 Historical Structure of the Industry
  2.5.2 Barriers of Market Entry
  2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity

3 UNITED STATES VS CHINA VS REST OF THE WORLD

3.1 United States VS China: Peptide Screening Service Market Comparison
  3.1.1 United States VS China: Peptide Screening Service Market Size Comparison (2017 & 2021 & 2028)
  3.1.2 United States VS China: Peptide Screening Service Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Peptide Screening Service Major Players and Market Share, 2017-2022
  3.2.1 Major Players of Peptide Screening Service in United States, Headquarters (States, Country)
  3.2.2 United States Peptide Screening Service Revenue by Domestic Player, (2017-2022)
3.3 China Peptide Screening Service Major Players and Market Share, 2017-2022
  3.3.1 Major Players of Peptide Screening Service in China, Headquarters (Province, Country)
  3.3.2 China Peptide Screening Service Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Peptide Screening Service Major Players and Market Share, 2017-2022
  3.4.1 Major Players of Peptide Screening Service in Rest of World, Headquarters (State, Country)
  3.4.2 Rest of World Peptide Screening Service Revenue by Domestic Player, (2017-2022)

4 MARKET ANALYSIS BY TYPE

4.1 World Peptide Screening Service Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
  4.2.1 Solid-Phase Screening
  4.2.2 Solution-Sorting Screening
  4.2.3 Cell-based Screening
  4.2.4 In Vivo Screening
  4.2.5 Ex Vivo Screening
4.3 Market Segment by Type
  4.3.1 World Peptide Screening Service Market Size by Type (2017-2022)
  4.3.2 World Peptide Screening Service Market Size by Type (2023-2028)
  4.3.3 World Peptide Screening Service Market Size Market Share by Type (2017-2028)

5 MARKET ANALYSIS BY APPLICATION

5.1 World Peptide Screening Service Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
  5.2.1 Structural Biology
  5.2.2 Peptide Drug Development
  5.2.3 Vaccine Development
5.3 Market Segment by Application
  5.3.1 World Peptide Screening Service Market Size by Application (2017-2022)
  5.3.2 World Peptide Screening Service Market Size by Application (2023-2028)
  5.3.3 World Peptide Screening Service Market Size by Application (2017-2028)

6 COMPANY PROFILES

6.1 Pepscan
  6.1.1 Pepscan Details
  6.1.2 Pepscan Major Business
  6.1.3 Pepscan Peptide Screening Service Product and Services
  6.1.4 Pepscan Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.1.5 Pepscan Recent Developments/Updates
  6.1.6 Pepscan Competitive Strengths & Weaknesses
6.2 Orbit Discovery
  6.2.1 Orbit Discovery Details
  6.2.2 Orbit Discovery Major Business
  6.2.3 Orbit Discovery Peptide Screening Service Product and Services
  6.2.4 Orbit Discovery Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.2.5 Orbit Discovery Recent Developments/Updates
  6.2.6 Orbit Discovery Competitive Strengths & Weaknesses
6.3 Creative Biolabs
  6.3.1 Creative Biolabs Details
  6.3.2 Creative Biolabs Major Business
  6.3.3 Creative Biolabs Peptide Screening Service Product and Services
  6.3.4 Creative Biolabs Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.3.5 Creative Biolabs Recent Developments/Updates
  6.3.6 Creative Biolabs Competitive Strengths & Weaknesses
6.4 GenScript
  6.4.1 GenScript Details
  6.4.2 GenScript Major Business
  6.4.3 GenScript Peptide Screening Service Product and Services
  6.4.4 GenScript Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.4.5 GenScript Recent Developments/Updates
  6.4.6 GenScript Competitive Strengths & Weaknesses
6.5 Creative Peptides
  6.5.1 Creative Peptides Details
  6.5.2 Creative Peptides Major Business
  6.5.3 Creative Peptides Peptide Screening Service Product and Services
  6.5.4 Creative Peptides Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.5.5 Creative Peptides Recent Developments/Updates
  6.5.6 Creative Peptides Competitive Strengths & Weaknesses
6.6 Eurogentec
  6.6.1 Eurogentec Details
  6.6.2 Eurogentec Major Business
  6.6.3 Eurogentec Peptide Screening Service Product and Services
  6.6.4 Eurogentec Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.6.5 Eurogentec Recent Developments/Updates
  6.6.6 Eurogentec Competitive Strengths & Weaknesses
6.7 Bio-Synthesis
  6.7.1 Bio-Synthesis Details
  6.7.2 Bio-Synthesis Major Business
  6.7.3 Bio-Synthesis Peptide Screening Service Product and Services
  6.7.4 Bio-Synthesis Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.7.5 Bio-Synthesis Recent Developments/Updates
  6.7.6 Bio-Synthesis Competitive Strengths & Weaknesses
6.8 JPT Peptide Technologies
  6.8.1 JPT Peptide Technologies Details
  6.8.2 JPT Peptide Technologies Major Business
  6.8.3 JPT Peptide Technologies Peptide Screening Service Product and Services
  6.8.4 JPT Peptide Technologies Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.8.5 JPT Peptide Technologies Recent Developments/Updates
  6.8.6 JPT Peptide Technologies Competitive Strengths & Weaknesses
6.9 Antibody Design Labs
  6.9.1 Antibody Design Labs Details
  6.9.2 Antibody Design Labs Major Business
  6.9.3 Antibody Design Labs Peptide Screening Service Product and Services
  6.9.4 Antibody Design Labs Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.9.5 Antibody Design Labs Recent Developments/Updates
  6.9.6 Antibody Design Labs Competitive Strengths & Weaknesses
6.10 HLA Proteins
  6.10.1 HLA Proteins Details
  6.10.2 HLA Proteins Major Business
  6.10.3 HLA Proteins Peptide Screening Service Product and Services
  6.10.4 HLA Proteins Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.10.5 HLA Proteins Recent Developments/Updates
  6.10.6 HLA Proteins Competitive Strengths & Weaknesses
6.11 Synbio Technologies
  6.11.1 Synbio Technologies Details
  6.11.2 Synbio Technologies Major Business
  6.11.3 Synbio Technologies Peptide Screening Service Product and Services
  6.11.4 Synbio Technologies Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.11.5 Synbio Technologies Recent Developments/Updates
  6.11.6 Synbio Technologies Competitive Strengths & Weaknesses
6.12 Lugen SCI
  6.12.1 Lugen SCI Details
  6.12.2 Lugen SCI Major Business
  6.12.3 Lugen SCI Peptide Screening Service Product and Services
  6.12.4 Lugen SCI Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.12.5 Lugen SCI Recent Developments/Updates
  6.12.6 Lugen SCI Competitive Strengths & Weaknesses
6.13 Quimigen
  6.13.1 Quimigen Details
  6.13.2 Quimigen Major Business
  6.13.3 Quimigen Peptide Screening Service Product and Services
  6.13.4 Quimigen Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.13.5 Quimigen Recent Developments/Updates
  6.13.6 Quimigen Competitive Strengths & Weaknesses
6.14 IRBM
  6.14.1 IRBM Details
  6.14.2 IRBM Major Business
  6.14.3 IRBM Peptide Screening Service Product and Services
  6.14.4 IRBM Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.14.5 IRBM Recent Developments/Updates
  6.14.6 IRBM Competitive Strengths & Weaknesses
6.15 BIOSTEM
  6.15.1 BIOSTEM Details
  6.15.2 BIOSTEM Major Business
  6.15.3 BIOSTEM Peptide Screening Service Product and Services
  6.15.4 BIOSTEM Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022)
  6.15.5 BIOSTEM Recent Developments/Updates
  6.15.6 BIOSTEM Competitive Strengths & Weaknesses

7 RAW MATERIAL AND INDUSTRY CHAIN

7.1 Raw Material of Peptide Screening Service and Key Manufacturers
7.2 Peptide Screening Service Manufacturing Costs
7.3 Peptide Screening Service Production Process
7.4 Peptide Screening Service Industrial Chain

8 DISTRIBUTION CHANNEL ANALYSIS

8.1 Distribution Channel Breakdown for Peptide Screening Service Shipments (%): 2017-2028
  8.1.1 Direct Channel
  8.1.2 Indirect Channel
8.2 Peptide Screening Service Typical Distributors
8.3 Peptide Screening Service Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Peptide Screening Service Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Peptide Screening Service Market Size by Region (2017-2022) & (USD Million)
Table 3. World Peptide Screening Service Market Size by Region (2023-2028) & (USD Million)
Table 4. World Peptide Screening Service Market Size Market Share by Region (2017-2022)
Table 5. World Peptide Screening Service Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Peptide Screening Service Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Peptide Screening Service Players in 2021
Table 9. World Peptide Screening Service Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Peptide Screening Service Company Evaluation Quadrant
Table 11. Head Office of Key Peptide Screening Service Player
Table 12. Peptide Screening Service Market: Company Product Type Footprint
Table 13. Peptide Screening Service Market: Company Product Application Footprint
Table 14. Peptide Screening Service Mergers & Acquisitions Activity
Table 15. United States VS China Peptide Screening Service Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Peptide Screening Service in United States, Headquarters (States, Country)
Table 17. United States Peptide Screening Service Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Peptide Screening Service Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Peptide Screening Service in China, Company Headquarters (Province, Country)
Table 20. China Peptide Screening Service Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Peptide Screening Service Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Peptide Screening Service in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Peptide Screening Service Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Peptide Screening Service Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Peptide Screening Service Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Peptide Screening Service Revenue by Type (2017-2022) & (USD Million)
Table 27. World Peptide Screening Service Revenue by Type (2023-2028) & (USD Million)
Table 28. World Peptide Screening Service Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Peptide Screening Service Revenue by Application (2017-2022) & (USD Million)
Table 30. World Peptide Screening Service Revenue by Application (2023-2028) & (USD Million)
Table 31. Pepscan Basic Information, Manufacturing Base and Competitors
Table 32. Pepscan Major Business
Table 33. Pepscan Peptide Screening Service Product and Services
Table 34. Pepscan Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Pepscan Recent Developments/Updates
Table 36. Pepscan Competitive Strengths & Weaknesses
Table 37. Orbit Discovery Basic Information, Manufacturing Base and Competitors
Table 38. Orbit Discovery Major Business
Table 39. Orbit Discovery Peptide Screening Service Product and Services
Table 40. Orbit Discovery Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Orbit Discovery Recent Developments/Updates
Table 42. Orbit Discovery Competitive Strengths & Weaknesses
Table 43. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 44. Creative Biolabs Major Business
Table 45. Creative Biolabs Peptide Screening Service Product and Services
Table 46. Creative Biolabs Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Creative Biolabs Recent Developments/Updates
Table 48. Creative Biolabs Competitive Strengths & Weaknesses
Table 49. GenScript Basic Information, Manufacturing Base and Competitors
Table 50. GenScript Major Business
Table 51. GenScript Peptide Screening Service Product and Services
Table 52. GenScript Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. GenScript Recent Developments/Updates
Table 54. GenScript Competitive Strengths & Weaknesses
Table 55. Creative Peptides Basic Information, Manufacturing Base and Competitors
Table 56. Creative Peptides Major Business
Table 57. Creative Peptides Peptide Screening Service Product and Services
Table 58. Creative Peptides Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Creative Peptides Recent Developments/Updates
Table 60. Creative Peptides Competitive Strengths & Weaknesses
Table 61. Eurogentec Basic Information, Manufacturing Base and Competitors
Table 62. Eurogentec Major Business
Table 63. Eurogentec Peptide Screening Service Product and Services
Table 64. Eurogentec Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Eurogentec Recent Developments/Updates
Table 66. Eurogentec Competitive Strengths & Weaknesses
Table 67. Bio-Synthesis Basic Information, Manufacturing Base and Competitors
Table 68. Bio-Synthesis Major Business
Table 69. Bio-Synthesis Peptide Screening Service Product and Services
Table 70. Bio-Synthesis Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Bio-Synthesis Recent Developments/Updates
Table 72. Bio-Synthesis Competitive Strengths & Weaknesses
Table 73. JPT Peptide Technologies Basic Information, Manufacturing Base and Competitors
Table 74. JPT Peptide Technologies Major Business
Table 75. JPT Peptide Technologies Peptide Screening Service Product and Services
Table 76. JPT Peptide Technologies Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. JPT Peptide Technologies Recent Developments/Updates
Table 78. JPT Peptide Technologies Competitive Strengths & Weaknesses
Table 79. Antibody Design Labs Basic Information, Manufacturing Base and Competitors
Table 80. Antibody Design Labs Major Business
Table 81. Antibody Design Labs Peptide Screening Service Product and Services
Table 82. Antibody Design Labs Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Antibody Design Labs Recent Developments/Updates
Table 84. Antibody Design Labs Competitive Strengths & Weaknesses
Table 85. HLA Proteins Basic Information, Manufacturing Base and Competitors
Table 86. HLA Proteins Major Business
Table 87. HLA Proteins Peptide Screening Service Product and Services
Table 88. HLA Proteins Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. HLA Proteins Recent Developments/Updates
Table 90. HLA Proteins Competitive Strengths & Weaknesses
Table 91. Synbio Technologies Basic Information, Manufacturing Base and Competitors
Table 92. Synbio Technologies Major Business
Table 93. Synbio Technologies Peptide Screening Service Product and Services
Table 94. Synbio Technologies Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Synbio Technologies Recent Developments/Updates
Table 96. Synbio Technologies Competitive Strengths & Weaknesses
Table 97. Lugen SCI Basic Information, Manufacturing Base and Competitors
Table 98. Lugen SCI Major Business
Table 99. Lugen SCI Peptide Screening Service Product and Services
Table 100. Lugen SCI Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Lugen SCI Recent Developments/Updates
Table 102. Lugen SCI Competitive Strengths & Weaknesses
Table 103. Quimigen Basic Information, Manufacturing Base and Competitors
Table 104. Quimigen Major Business
Table 105. Quimigen Peptide Screening Service Product and Services
Table 106. Quimigen Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Quimigen Recent Developments/Updates
Table 108. Quimigen Competitive Strengths & Weaknesses
Table 109. IRBM Basic Information, Manufacturing Base and Competitors
Table 110. IRBM Major Business
Table 111. IRBM Peptide Screening Service Product and Services
Table 112. IRBM Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. IRBM Recent Developments/Updates
Table 114. BIOSTEM Basic Information, Manufacturing Base and Competitors
Table 115. BIOSTEM Major Business
Table 116. BIOSTEM Peptide Screening Service Product and Services
Table 117. BIOSTEM Peptide Screening Service Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 118. Peptide Screening Service Raw Material
Table 119. Key Manufacturers of Peptide Screening Service Raw Materials
Table 120. Peptide Screening Service Typical Distributors
Table 121. Peptide Screening Service Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Peptide Screening Service Picture
Figure 2. World Peptide Screening Service Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Peptide Screening Service Total Market Size (2017-2028) & (USD Million)
Figure 4. World Peptide Screening Service Market Size Market Share by Region (2017-2028)
Figure 5. United States Peptide Screening Service Market Size (2017-2028) & (USD Million)
Figure 6. China Peptide Screening Service Market Size (2017-2028) & (USD Million)
Figure 7. Europe Peptide Screening Service Market Size (2017-2028) & (USD Million)
Figure 8. Japan Peptide Screening Service Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Peptide Screening Service Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Peptide Screening Service Market Size (2017-2028) & (USD Million)
Figure 11. India Peptide Screening Service Market Size (2017-2028) & (USD Million)
Figure 12. Peptide Screening Service Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Peptide Screening Service by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Peptide Screening Service Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Peptide Screening Service Markets in 2021
Figure 17. United States VS China: Peptide Screening Service Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Peptide Screening Service Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Peptide Screening Service Market Size Market Share by Type in 2021
Figure 20. Solid-Phase Screening
Figure 21. Solution-Sorting Screening
Figure 22. Cell-based Screening
Figure 23. In Vivo Screening
Figure 24. Ex Vivo Screening
Figure 25. World Peptide Screening Service Market Size Market Share by Type (2017-2028)
Figure 26. World Peptide Screening Service Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 27. World Peptide Screening Service Market Size Market Share by Application in 2021
Figure 28. Structural Biology
Figure 29. Peptide Drug Development
Figure 30. Vaccine Development
Figure 31. World Peptide Screening Service Market Size Market Share by Application (2017-2028)
Figure 32. Manufacturing Cost Structure Analysis of Peptide Screening Service in 2021
Figure 33. Manufacturing Process Analysis of Peptide Screening Service
Figure 34. Peptide Screening Service Industrial Chain
Figure 35. Distribution Channel Breakdown for Peptide Screening Service Shipments (%): 2017-2028
Figure 36. Direct Channel Pros & Cons
Figure 37. Indirect Channel Pros & Cons
Figure 38. Methodology
Figure 39. Research Process and Data Source